argenx to Highlight Key Data and Breadth of Immunology Innovation at 2025 AANEM Annual Meeting and MGFA Scientific Session
Pivotal ADAPT SERON results and interim ADAPT Jr data showcase VYVGART’s potential…
Vara earns CE mark as the only AI authorized for an independent second read in mammography, and expands in Europe
BERLIN, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Vara announced today it received…
ETC Announces Fiscal 2026 Second Quarter Results
SOUTHAMPTON, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Environmental Tectonics Corporation (OTCID:…
ASK4SAM: Silberstein & Miklos, P.C. Expands Focus on Commercial Vehicle Accident Cases in Fordham, the Bronx Truck and Bus Collisions
October 14, 2025 10:00 ET | Source: Silberstein & Miklos, P.C. Bronx,…
Criminal IP to Showcase ASM and CTI Innovations at GovWare 2025 in Singapore
Criminal IP at Booth J30 | Sands Expo Singapore | October 21…
Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine
October 14, 2025 08:05 ET | Source: Candel Therapeutics NEEDHAM, Mass., Oct.…
HealthEquity Introduces GLP-1 Telehealth and Direct HSA Enrollment Platforms
New Offerings Bring Millions Affordable Healthcare Solutions During Open Enrollment Season October…
CytoMed makes cash bid for potential acquisition of TC BioPharm Limiteds relevant assets
SINGAPORE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC)…
Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
- Plenary session oral presentation: Friday, October 24 10:00 -11:40 a.m. ET…
Quanta Therapeutics Announces First Clinical Data Presentation for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
RADNOR, Pa. and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE)…
